TCL Archive Amgen Web Site For Patients Goes Dark After Story In The Cancer Letter. November 16, 2007
TCL Archive Blueprint Group co-chairman Mark Ratain says group seeks “the perfect peer review system,” but a member’s email questions the proposal. August 13, 2004
TCL Archive Tesetaxel Showed 20 Percent Response In Second-Line Therapy In Phase IIb Trial January 27, 2012